KURES

kures-logo

Kures is a pre-clinical-stage biopharmaceutical startup that develops opioid-based treatments for depressive disorder. The biopharmaceutical company is also interested in addressing other challenging indications in the psychiatry and physical pain arena using its portfolio of novel small molecules. It is currently operating in Stealth mode. Andrew Kruegel established the biotech company in 2017 in Dobbs Ferry, New York.

#People #Website #More

KURES

Social Links:

Industry:
Alternative Medicine Biotechnology Health Care Therapeutics

Founded:
2017-01-01

Address:
Dobbs Ferry, New York, United States

Country:
United States

Website Url:
http://www.kures.life

Total Employee:
1+

Status:
Active

Contact:
(929) 265-7214

Email Addresses:
[email protected]

Total Funding:
4.24 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Euro GoDaddy DNS Google Google Cloud OpenResty Google Adsense Google Cloud Global Multi-Region AdBlock Acceptable Ads


Current Employees Featured

srinivas-rao_image

Srinivas Rao
Srinivas Rao CEO @ Kures
CEO

andrew-kruegel_image

Andrew Kruegel
Andrew Kruegel President, Chief Scientific Officer & Founder @ Kures
President, Chief Scientific Officer & Founder
2017-01-01

Founder


andrew-kruegel_image

Andrew Kruegel

Official Site Inspections

http://www.kures.life

  • Host name: 198.185.159.144
  • IP address: 198.185.159.144
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "Kures"

Kures - Crunchbase Company Profile & Funding

Kures is a pre-clinical-stage biopharmaceutical startup that develops opioid-based treatments for depressive disorder. The biopharmaceutical company is also interested in addressing other challenging indications in the psychiatry and โ€ฆSee details»

ATAI Life Sciences takes on opioid crisis by acquiring Kures to โ€ฆ

BERLIN and NEW YORK, July 9, 2020 /PRNewswire/ -- ATAI Life Sciences AG, a global biotechnology company builder that envisions an end to mental illnesses, has acquired a โ€ฆSee details»

ATAI Life Sciences takes on opioid crisis by acquiring Kures to โ€ฆ

Jul 9, 2020 Additionally, Srinivas Rao, MD, PhD, Chief Scientific Officer of ATAI Life Sciences, has been appointed CEO of Kures. "Joining ATAI's platform comes with much more than a โ€ฆSee details»

Kures Company Profile 2024: Valuation, Investors, Acquisition

Kures General Information Description. Developer of therapeutics intended for mood disorders. The company targets the important intersection between pain and opioid use disorder and its โ€ฆSee details»

atai Life Sciences Company Kures Therapeutics Appoints Dr. Chad โ€ฆ

Jun 30, 2022 Outgoing Kures CEO Dr. Srinivas Rao will continue to support and advise Kuresโ€™ programs from his role at atai Life Sciences. About Kures Therapeutics Kures is developing โ€ฆSee details»

Kures, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Apr 1, 2024 About Kures Therapeutics Kures Therapeutics, an atai Life Sciences Company, is a spinout from Columbia University and is developing KUR-101 for the treatment of OUD and โ€ฆSee details»

ATAI Life Sciences takes on opioid crisis by acquiring Kures to โ€ฆ

Jul 9, 2020 NEWS PROVIDED BY ATAI Life Sciences . Jul 09, 2020, 12:30 ET. BERLIN and NEW YORK, July 9, 2020 /PRNewswire/ โ€” ATAI Life Sciences AG, a global biotechnology โ€ฆSee details»

ATAI Life Sciences takes on opioid crisis by acquiring Kures

ATAI Life Sciences takes on opioid crisis by acquiring Kures ... - BioSpaceSee details»

atai Life Sciences Company Kures Therapeutics Appoints Dr. Chad โ€ฆ

Atai Life Sciences AG. Dr. Chad Beyer will join as CEO on July 1, 2022. NEW YORK, June 30, 2022 (GLOBE NEWSWIRE) -- Kures Therapeutics, Inc (โ€œKuresโ€), an atai Life Sciences N.V. โ€ฆSee details»

atai Life Sciences Announces Positive Initial Results for Phase 1 โ€ฆ

Oct 12, 2022 โ€œWeโ€™re pleased with the results of our initial Phase 1 findings of KUR-101,โ€ said Dr. Chad Beyer, CEO of Kures, a subsidiary of atai Life Sciences leading the KUR-101 program. โ€ฆSee details»

Kures - Org Chart, Teams, Culture & Jobs - The Org

Kures is a pre-clinical-stage biopharmaceutical startup that develops opioid-based treatments for depressive disorder.The biopharmaceutical company is also interested in addressing other โ€ฆSee details»

Andrew Kruegel - President, Chief Scientific Officer & Founder

Andrew is a medicinal chemist, neuroscientist, and entrepreneur with interdisciplinary expertise in drug development, with a particular focus on CNS disorders. He is currently engaged in the โ€ฆSee details»

ATAI Life Sciences acquiring Kures to develop novel therapeutics โ€ฆ

BERLIN and NEW YORK, July 9, 2020 /PRNewswire/ -- ATAI Life Sciences AG, a global biotechnology company builder that envisions an end to mental illnesses, has acquired a โ€ฆSee details»

Kures - Overview, News & Similar companies | ZoomInfo.com

View Kures (kures.life) location , revenue, industry and description. Find related and similar companies as well as employees by title and much more. ... Kures is a joint translational โ€ฆSee details»

About - Kures Apothecary

More than a modern apothecary, Kures is a wellness lifestyle brand created to help make life just a little bit brighter. For those seeking an alternative way of life Inspired by the classic โ€ฆSee details»

Startup aims to treat opioid use disorder with a kratom-derived drug

Oct 14, 2022 Atai Life Sciences (Nasdaq:ATAI) recently announced positive results from a Phase 1 study testing KUR-101 for opioid use disorder. KUR-101 is an oral formulation of the โ€ฆSee details»

User Stories: How Kratom Has Changed Lives - Kures Apothecary

Jul 3, 2024 Kratom has been a lifeline for many people trying to break free from addiction. Letโ€™s explore some real-life stories and research to understand how Kratom helps in this journey. โ€ฆSee details»

After psilocybin and ketamine, a new biotech comes along โ€ฆ

Jul 9, 2020 Andrew Kruegel, Kures president and co-founder (Columbia Tech Ventures via Vimeo) July 9, 2020 11:23 AM EDT Updated July 10, 12:52 PM. Startups. R&D. In Focus.See details»

Kures Apothecary: Redefining the Kratom Industry with โ€ฆ

May 4, 2023 As Kures continues to redefine the kratom industry with its emphasis on transparency and customer care, the companyโ€™s future seems brighter than ever. The โ€ฆSee details»

Kratom and Minimalism: Simplifying Your Life - kures.co

Aug 15, 2024 Simplicity of Life. Adding Kratom to your daily routine reduces the need to buy more costly medications as it approaches a natural and organic way to help you become โ€ฆSee details»